T1	Chemical	48 57	ribavirin
T2	Limited_variation	84 109	polymorphisms at ITPA and
T3	Pharmacodynamic_phenotype	110 131	treatment efficacy in
T4	Disease	132 160	chronic hepatitis C mediated
T5	Phenotype	172 186	relapse risk .
R1	isAssociatedWith	Arg1:T1	Arg2:T2
R2	isAssociatedWith	Arg1:T1	Arg2:T3
R3	isAssociatedWith	Arg1:T1	Arg2:T4
R4	decreases	Arg1:T1	Arg2:T5
R5	isAssociatedWith	Arg1:T2	Arg2:T1
R6	isAssociatedWith	Arg1:T2	Arg2:T3
R7	isAssociatedWith	Arg1:T2	Arg2:T4
R8	decreases	Arg1:T2	Arg2:T5
R9	isAssociatedWith	Arg1:T3	Arg2:T1
R10	isAssociatedWith	Arg1:T3	Arg2:T2
R11	treats	Arg1:T3	Arg2:T4
R12	decreases	Arg1:T3	Arg2:T5
R13	isAssociatedWith	Arg1:T4	Arg2:T1
R14	isAssociatedWith	Arg1:T4	Arg2:T2
R15	isAssociatedWith	Arg1:T4	Arg2:T3
R16	decreases	Arg1:T4	Arg2:T5
R17	isAssociatedWith	Arg1:T5	Arg2:T1
R18	isAssociatedWith	Arg1:T5	Arg2:T2
R19	isAssociatedWith	Arg1:T5	Arg2:T3
R20	isAssociatedWith	Arg1:T5	Arg2:T4
